Indrani Lall Franchini, EVP, Chief Compliance Officer at ALEXION PHARMACEUTICALS, INC. (ALXN), sold 13,676 shares at $115.00 ($1.6M) on 2020-06-08, disclosed to the SEC on 2020-06-09.
Seasonal sale ($1.6M) by EVP, Chief Compliance Officer — this insider has traded ALXN in June in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $114.61 | 1,403 | $161K | 10.3% |
| 2 | $114.61 | 5,420 | $621K | 39.6% |
| 3 | $114.61 | 5,420 | $621K | 39.6% |
| 4 | $115.00 | 1,433 | $165K | 10.5% |
| Total | $114.65 avg | 13,676 | $1.6M | 100% |
| Filing → |
| ALNY | SELL | 2023-04-10 | $735K | — | Filing → |
| ALNY | SELL | 2023-02-03 | $739K | — | Filing → |
| ALXN | SELL | 2019-07-02 | $598K | — | Filing → |